e8vk
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2006
 
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware   001-31441   23-2872718
(State or other jurisdiction of   (Commission File   (I.R.S. Employer
Incorporation)   Number)   Identification No.)
 
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055
(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
SIGNATURE
EXHIBIT INDEX
Select Medical Corporation press release, dated November 10, 2006


Table of Contents

Item 2.02 Results of Operations and Financial Condition.
     On November 10, 2006, Select Medical Corporation issued a press release reporting its results for its third quarter ended September 30, 2006. A copy of the press release is attached as Exhibit 99.1 to this report.
     The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
             
    SELECT MEDICAL CORPORATION    
 
           
Date: November 13, 2006
  By:      /s/ Michael E. Tarvin
 
Michael E. Tarvin
   
 
      Senior Vice President, General Counsel and Secretary    

 


Table of Contents

EXHIBIT INDEX
     
Exhibit No.   Description
 
   
99.1
  Select Medical Corporation press release, dated November 10, 2006.